Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William Pate currently holds 385 shares of Adams Respiratory Therapeutics, Inc. (ARXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Pate has been a net seller of ARXT stock. They have purchased $1.1M and sold $10.8M worth of shares.
William Pate's most recent insider trade was on Apr 5, 2026, when they sold 385 shares at $0.00 per share.
William Pate serves as Executive at Adams Respiratory Therapeutics, Inc. (ARXT). They have executed 152 insider transactions totaling $11.9M over their tenure at the company.
William Pate holds the position of Executive at Adams Respiratory Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
William Pate has shown a selling trading pattern, with $1.1M in total purchases and $10.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by William Pate was on Aug 14, 2023, when they sold $5.2M worth of PARR shares. This transaction involved 150,000 shares at $34.85 per share.
William Pate currently owns 385 shares of Adams Respiratory Therapeutics, Inc. (ARXT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William Pate's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William Pate has 152 Form 4 filings on record as an insider at Adams Respiratory Therapeutics, Inc..
Set alerts for William Pate and 40,000+ other insiders.